Comparing Cancer Care, Outcomes, and Costs Across Health Systems: Charting the Course-Reference-Cited by-同舟云学术

Comparing Cancer Care, Outcomes, and Costs Across Health Systems: Charting the Course

Published:2013-08-01 Issue:46 Volume:2013 Page:124-130
ISSN:1052-6773
Container-title:JNCI Monographs
language:en
Short-container-title:JNCI Monographs

Author:

Lipscomb J.,Yabroff K. R.,Hornbrook M. C.,Gigli A.,Francisci S.,Krahn M.,Gatta G.,Trama A.,Ritzwoller D. P.,Durand-Zaleski I.,Salloum R.,Chawla N.,Angiolini C.,Crocetti E.,Giusti F.,Guzzinati S.,Mezzetti M.,Miccinesi G.,Mariotto A.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology,General Medicine

Link

http://academic.oup.com/jncimono/article-pdf/2013/46/124/2899549/lgt011.pdf

Reference45 articles.

1. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary

2. Cancer survival in five continents: a worldwide population-based study (CONCORD)

3. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis

4. Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Explaining regional variations in colon cancer survival in Ontario, Canada: a population-based retrospective cohort study;BMJ Open;2022-09

2. Cancer Survivorship and Supportive Care Economics Research: Current Challenges and Next Steps;JNCI Monographs;2022-07-01

3. Patterns of Medical Care Cost by Service Type for Patients With Recurrent and De Novo Advanced Cancer;Value in Health;2022-01

4. A population-based comparison of treatment, resource utilization, and costs by cancer stage for Ontario patients with HER2-positive breast cancer;Breast Cancer Research and Treatment;2020-10-22

5. A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancer;Breast Cancer Research and Treatment;2020-10-16